NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 261 filers reported holding NATERA INC in Q2 2022. The put-call ratio across all filers is 1.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $18,431,000 | +26.4% | 420,605 | +2.3% | 0.70% | +21.8% |
| Q2 2022 | $14,576,000 | -8.3% | 411,276 | +5.3% | 0.58% | +9.7% |
| Q1 2022 | $15,887,000 | -55.4% | 390,540 | +2.4% | 0.53% | -50.5% |
| Q4 2021 | $35,609,000 | -17.3% | 381,296 | -1.3% | 1.07% | -19.8% |
| Q3 2021 | $43,049,000 | +21.0% | 386,296 | +23.3% | 1.33% | +25.6% |
| Q2 2021 | $35,578,000 | +10.4% | 313,380 | -1.3% | 1.06% | +2.2% |
| Q1 2021 | $32,226,000 | -43.9% | 317,374 | -45.0% | 1.04% | -45.5% |
| Q4 2020 | $57,407,000 | -0.9% | 576,839 | -28.1% | 1.90% | -24.5% |
| Q3 2020 | $57,932,000 | +31.6% | 801,941 | -9.2% | 2.52% | +27.4% |
| Q2 2020 | $44,038,000 | +50.6% | 883,227 | -9.8% | 1.97% | +18.1% |
| Q1 2020 | $29,238,000 | +140.0% | 979,176 | +170.8% | 1.67% | +217.7% |
| Q4 2019 | $12,184,000 | +11.1% | 361,644 | +8.2% | 0.53% | -6.1% |
| Q3 2019 | $10,963,000 | – | 334,244 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |